| Refresh | This website www.iipta.com/tag/high-court/ is currently offline. Cloudflare's Always Online™ shows a snapshot of this web page from the Internet Archive's Wayback Machine. To check for the live version, click Refresh. |
In a recent development that could have major ramifications on intellectual property cases in pharmaceutical and technology sectors, the Delhi High Court issued a notice to the government in a PIL (Public Interest Litigation) filed by Mr. Shamnad Basheer in regard to the “working statement” of patented inventions in India. Mandatory Requirement To Furnish [...]
The Delhi High Court allowed Pharma company Cipla to produce the generic version of the anti-cancer drug Nexavar and directed the drug regulator to grant it licence. Earlier, German drug major Bayer Healthcare had filed a suit against Cipla stating that they do not have the right to manufacture the drug as the sole [...]
